Citation

Horne AD, Clifford J, Goldenthal KL, Kleppinger C, Lachenbruch PA. Vaccine 2004; 23(1): 84-90.

Affiliation

Division of Biostatistics, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research (CBER), FDA, HFM-217, 1401 Rockville Pike, Rockville, MD 20852-1448, USA. horne@cber.fda.gov

Copyright

(Copyright © 2004, Elsevier Publishing)

DOI

10.1016/j.vaccine.2004.04.037

PMID

15519711

Abstract

This paper discusses the US Food and Drug Administration's approach to evaluation of vaccines in general, and vaccines against diseases of bioterrorism in particular. We summarize the scientific bases for development and approval of vaccines and then discuss specific issues regarding vaccines against disease organisms that could potentially be used as weapons of bioterrorism.

Language: en